Halozyme(HALO) - 2024 Q4 - Earnings Call Presentation

Fourth Quarter and FY 2024 Financial & Operating Results Halozyme Therapeutics, Inc. NASDAQ: HALO February 18, 2025 1 Forward-Looking Statements In addition to historical information, the statements set forth in this presentation include forward-looking statements including, without limitation, statements concerning the Company's expected future financial performance and growth rates (including the Company's 2025 financial guidance and longer term financial outlook through 2028 and the assumptions used in d ...